COVID vaccination provider bulletin 24 October
Booster dose change for some children
ATAGI recommends that a booster dose of Pfizer 5-11 may be given to children aged 5-11 years who are severely immunocompromised, have a disability with complex needs, or have complex/multiple health conditions that increase the risk of severe COVID-19. The recommended interval between a primary course or a COVID-19 infection and a booster dose remains at three months.
Click here to read the full bulletin.